TR200000725T2 - Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi - Google Patents

Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi

Info

Publication number
TR200000725T2
TR200000725T2 TR2000/00725T TR200000725T TR200000725T2 TR 200000725 T2 TR200000725 T2 TR 200000725T2 TR 2000/00725 T TR2000/00725 T TR 2000/00725T TR 200000725 T TR200000725 T TR 200000725T TR 200000725 T2 TR200000725 T2 TR 200000725T2
Authority
TR
Turkey
Prior art keywords
composition
alkyl
monoamine oxidase
oxidase inhibitor
formula
Prior art date
Application number
TR2000/00725T
Other languages
English (en)
Turkish (tr)
Inventor
Berg Stefan
Ross Svante
Thorberg Seth-Olov
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200000725T2 publication Critical patent/TR200000725T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2000/00725T 1997-09-18 1998-09-09 Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi TR200000725T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703376A SE9703376D0 (sv) 1997-09-18 1997-09-18 A new combination

Publications (1)

Publication Number Publication Date
TR200000725T2 true TR200000725T2 (tr) 2000-08-21

Family

ID=20408296

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00725T TR200000725T2 (tr) 1997-09-18 1998-09-09 Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi

Country Status (27)

Country Link
US (1) US6159970A (enExample)
EP (1) EP1014986B1 (enExample)
JP (1) JP2001516719A (enExample)
KR (2) KR20010024087A (enExample)
CN (1) CN1278727A (enExample)
AR (1) AR013503A1 (enExample)
AT (1) ATE270889T1 (enExample)
AU (1) AU752719B2 (enExample)
BR (1) BR9812236A (enExample)
CA (1) CA2302204A1 (enExample)
DE (1) DE69825062T2 (enExample)
DK (1) DK1014986T3 (enExample)
EE (1) EE200000146A (enExample)
ES (1) ES2222603T3 (enExample)
HU (1) HUP0100621A2 (enExample)
ID (1) ID25789A (enExample)
IL (1) IL134775A0 (enExample)
IS (1) IS5401A (enExample)
MX (1) MXPA00002616A (enExample)
NO (1) NO20001400L (enExample)
PL (1) PL339368A1 (enExample)
PT (1) PT1014986E (enExample)
SE (1) SE9703376D0 (enExample)
SK (1) SK2832000A3 (enExample)
TR (1) TR200000725T2 (enExample)
WO (1) WO1999013878A1 (enExample)
ZA (1) ZA987804B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
SE9601110D0 (sv) 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
ES2323451T7 (es) * 2001-07-20 2011-08-01 Psychogenics Inc. Tratamiento para el trastorno de hiperactividad con deficit de atencion.
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US20090054453A1 (en) * 2006-03-17 2009-02-26 Lilian Alcaraz Novel Tetralins as 5-HT6 Modulators
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
SI2091948T1 (sl) 2006-11-30 2012-07-31 Probiodrug Ag Novi inhibitorji glutaminil ciklaze
EA200901140A1 (ru) 2007-03-01 2010-04-30 Пробиодруг Аг Новое применение ингибиторов глутаминилциклазы
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
CN102695546B (zh) 2009-09-11 2014-09-10 前体生物药物股份公司 作为谷氨酰胺酰环化酶抑制剂的杂环衍生物
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
SG183229A1 (en) 2010-03-10 2012-09-27 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
DK3461819T3 (da) 2017-09-29 2020-08-10 Probiodrug Ag Inhibitorer af glutaminylcyklase
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN110179988A (zh) * 2019-07-10 2019-08-30 王大伟 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用
EP4633638A1 (en) * 2022-12-14 2025-10-22 Luminous Mind Inc. Treatment of psychological factors affecting other medical conditions (pfaomc)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
DE69232003T2 (de) * 1991-09-18 2002-04-25 Glaxo Group Ltd., Greenford Benzanilidderivate als 5-HT1D-Antagonisten
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
US6159970A (en) 2000-12-12
DE69825062D1 (de) 2004-08-19
SK2832000A3 (en) 2000-09-12
CA2302204A1 (en) 1999-03-25
NO20001400L (no) 2000-05-05
NO20001400D0 (no) 2000-03-17
SE9703376D0 (sv) 1997-09-18
ZA987804B (en) 1999-03-18
HUP0100621A2 (hu) 2001-08-28
ES2222603T3 (es) 2005-02-01
AU752719B2 (en) 2002-09-26
EP1014986A1 (en) 2000-07-05
JP2001516719A (ja) 2001-10-02
MXPA00002616A (es) 2002-04-24
DK1014986T3 (da) 2004-10-25
IS5401A (is) 2000-03-14
EE200000146A (et) 2001-02-15
CN1278727A (zh) 2001-01-03
ID25789A (id) 2000-11-02
ATE270889T1 (de) 2004-07-15
AR013503A1 (es) 2000-12-27
PT1014986E (pt) 2004-10-29
EP1014986B1 (en) 2004-07-14
KR20010024084A (ko) 2001-03-26
PL339368A1 (en) 2000-12-18
BR9812236A (pt) 2000-07-18
KR20010024087A (ko) 2001-03-26
IL134775A0 (en) 2001-04-30
DE69825062T2 (de) 2005-08-25
AU9193198A (en) 1999-04-05
WO1999013878A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
TR200000725T2 (tr) Bir monoamin oksidaz inhibitörü ve h5-HT1B antagonistinin bileşimi
TR200000727T2 (tr) 5HT geri alım inhibitörü ve h5-HT1B antagonistinin bir bileşimi.
DK1392714T3 (da) Steroider som agonister for FXR
HUP0300138A2 (en) Cyclic amine derivatives as ccr5 antagonists, their production and use and pharmaceutical compositions containing them
TR199801594A2 (xx) CCR-3 resept�r antagonistleri.
NO20034523D0 (no) Pyrazolderivater for behandling av HIV
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
PL374019A1 (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
HUP0302157A2 (hu) 4-(2-Fenil-tiazol-5-il)-1,4-diazabiciklo[3.2.2]nonán-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
CO5550439A2 (es) Compuestos derivados de arilsulfonil-piperazina que tienen afinidad al receptor 5-ht6 y composiciones farmaceuticas que los contienen
ATE270289T1 (de) Heteroaryloxypropanolamine als beta3- adrenergischer rezeptor-agonisten
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
ATE384714T1 (de) Pyrazolderivate
NO910167D0 (no) Haarfargemiddel.
NO20041704L (no) Substituerte alkylaminopyridazinonderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som inneholder disse
BR0314759A (pt) Derivados de pirazol
DK0876393T3 (da) 21-(2-oxo-tetrahydrofuran)-thio-pregnanderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indehold
SE9703374D0 (sv) A new combination
KR960007560A (ko) 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
DK0782574T3 (da) Bicycliske carboxiamider som 5-HT1A-receptorligander
HUP0402149A2 (hu) Vízoldható fenil-piridazin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
PT99207A (pt) Processo de preparacao de derivados da piperidina e de composicoes farmaceuticas
SE9800835D0 (sv) New Compounds
BG101287A (en) Microbicidal composition